Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Expenditure and Reaction Time

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-35
SponsorHofstra University

About this trial

Capsimax is a novel, proprietary encapsulated form of capsaicin, a natural and bioactive phytochemical found in chili pepper and other spicy food. The purpose of this study is to investigate the effect of Capsimax on resistance exercise performance, reaction time, and resting energy expenditure around exercise. This investigation will also measure muscle oxygenation and intramuscular nitric oxide in real time during resistance exercise using a non-invasive wearable technology.

Primary Objective • To examine the effects of Capsimax on physical performance metrics including peak power and rate of force development during an isometric strength test and performance during the barbell back squat exercise protocol (e.g., repetitions performed, total volume, peak power, average power).

Secondary Objectives

* To examine the effects of Capsimax on resting energy expenditure around exercise. * To examine the effects of Capsimax on nitric oxide bioavailability and skeletal muscle oxygenation during exercise.

Exploratory Objective

• To examine the effects of Capsimax on reaction time around exercise

Eligibility criteria

Qualifiers

Male subjects aged between 18-35 years (both limits inclusive).

Subjects must have a BMI of 18.5 to 29.9 kg/m2 (both limits inclusive)

Subjects must have greater than one year of resistance training experience at a frequency of 2 days per week.

Subjects must be proficient in the barbell back squat exercise.

Disqualifiers

Subjects who have hypersensitivity or history of allergy to the study product.

Subjects with inability to swallow soft gel capsules.

Subjects with any other medical condition that might adversely impact the safety of the study participants or confound the study results.

Subjects who require medications.

Trial design

Treatments tested in this trial

  • A novel, proprietary encapsulated form of Capsicum extract in beadlet form standardized to 2% capsaicinoids

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hofstra University

Lead sponsor

OmniActive Health Technologies

Collaborator